Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly developed form of CRISPR at UNSW Sydney points to a safer way of treating ...

As the open web prepares to enter a critical new phase in 2026, one theme unites voices across the industry: quality will ...

The lack of gains in productivity from AI could stall adoption and burst the economic bubble. Is there a rational explanation ...

The Wild West era of 3D printing, which early adopters like me have enjoyed for so long, is fading away. But as the industry ...

AI Impact breaks down AI’s slow productivity curve, real-world healthcare gains, executive moves and Newsweek AI Impact ...

The Public Works Department (PWD) has implemented new protocols influenced by the Central Vigilance Commission, mandating ...

The extraordinary profits and payouts of private markets attract too many copycats and pretenders (“The New Private-Equity Billionaires Who Are Taking Over Wall Street,” Cover Story, Dec. 5).

Large-cap US equities via low-cost ETFs led 2025 returns, beating active and small caps, with S&P 500 gains from profits.

In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

Dec. 4 (UPI) --The Center for Advancement of Science in Space will continue to manage the International Space Station National Laboratory for at least another five years, CASIS announced on Thursday.

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...